Williams v. AstraZeneca Pharmaceuticals LP et al
Filing
91
STIPULATION AND ORDER re (90 in 3:16-cv-07152-JST) STIPULATION WITH PROPOSED ORDER to Continue Hearing of Plaintiff's Motion to Dismiss and to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesso n Corporation, Bristol-Myers Squibb Company, (47 in 3:17-cv-00661-JST) STIPULATION WITH PROPOSED ORDER to Continue Hearing of Plaintiff's Motion to Dismiss and to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol-Myers Company. Signed by Judge Jon S. Tigar on September 28, 2017. (wsn, COURT STAFF) (Filed on 9/28/2017)
1
5
TIMOTHY M. CLARK (Bar No. 284447)
tclark@thesandersfirm.com
LAUREN A. WELLING (Bar No. 291813)
lwelling@thesandersfirm.com
SANDERS PHILLIPS GROSSMAN, LLC
2860 Michelle Drive, Suite 220
Irvine, CA 92606
Telephone:
+1 877 480 9142
Facsimile:
+1 213 330 0346
6
Attorneys for Plaintiffs
7
DONALD F. ZIMMER, JR. (Bar No. 112279)
fzimmer@kslaw.com
WILLIAM E. STEIMLE (Bar No. 203426)
wsteimle@kslaw.com
KING & SPALDING LLP
101 Second Street, Suite 2300
San Francisco, CA 94105
Telephone:
+1 415 318 1200
Facsimile:
+1 415 318 1300
2
3
4
8
9
10
11
12 Attorneys for Defendants
BRISTOL-MYERS SQUIBB COMPANY,
13 ASTRAZENECA PHARMACEUTICALS LP,
and MCKESSON CORPORATION
14
IN THE UNITED STATES DISTRICT COURT
15
FOR THE NORTHERN DISTRICT OF CALIFORNIA
16
17 CAROLYN WILLIAMS,
Case No.: 3:16-CV-07152-JST
18
STIPULATION AND [PROPOSED]
ORDER TO CONTINUE HEARING OF
PLAINTIFF’S MOTION TO DISMISS
AND TO CONTINUE CASE
MANAGEMENT CONFERENCE
PURSUANT TO N.D. CAL. CIV. L.R. 6-1
19
Plaintiff,
v.
20 ASTRAZENECA PHARMACEUTICALS
LP, et al.,
21
Defendants.
22
23
Honorable Jon S. Tigar
AND RELATED ACTION:
24
Judge:
Michael Martin v. Bristol-Myers Squibb
Company, et al.,
Case No. 4:17-cv-00661-JST
25
26
27
28
STIPULATION AND [PROPOSED] ORDER TO CONTINUE HEARING OF PLAINTIFF’S MOTION
TO DISMISS AND TO CONTINUE CASE MANAGEMENT CONFERENCE PURSUANT TO N.D.
CAL. CIV. L.R. 6-1 - 3:16-CV-07152-JST
1
WHEREAS, on August 18, 2017, Defendants Bristol-Myers Squibb Company,
2
AstraZeneca Pharmaceuticals LP, and McKesson Corporation (“Defendants”) filed a motion
3
seeking a determination of whether subject matter jurisdiction exists in these related cases, which
4
was originally scheduled for hearing on September 28, 2017, at 2:00 p.m. [Doc. 74];
5
WHEREAS, on September 1, 2017, Plaintiffs filed a motion to dismiss McKesson
6
Corporation as a defendant in these cases, which motion is scheduled to be heard on October 12,
7
2017, at 2:00 p.m. [Doc. 81];
8
9
WHEREAS, a case management conference had previously been scheduled to occur on
September 20, 2017;
10
WHEREAS, the parties submitted a stipulation and proposed order seeking to have the
11
above two motions and the case management conference heard on September 28, 2017 [Doc.
12
86];
13
WHEREAS, the Court denied the request to have the motions and case management
14
conference heard on September 28, 2017, and instead ordered that the case management
15
conference be continued to October 12, 2017, and the subject matter jurisdiction motion be
16
continued to November 9, 2017 [Doc. 88];
17
18
WHEREAS, counsel for Defendants is unavailable from October 12, 2017, through
October 15, 2017, due to a prepaid, long-planned, and non-refundable vacation;
19
20
WHEREAS, the parties have consulted the Court’s calendar regarding dates on which the
Court is unavailable;
21
22
WHEREAS, the next date that the Court and the parties are available is November 2,
2017;
23
NOW, THEREFORE, the Parties stipulate as follows:
24
The October 12, 2017 hearing of Plaintiff’s motion to dismiss McKesson Corporation be
25
continued to November 2, 2017.
26
///
27
///
28
2
STIPULATION AND [PROPOSED] ORDER TO CONTINUE HEARING OF PLAINTIFF’S MOTION
TO DISMISS AND TO CONTINUE CASE MANAGEMENT CONFERENCE PURSUANT TO N.D.
CAL. CIV. L.R. 6-1
1
The case management conference scheduled for October 12, 2017, be continued to
2
November 2, 2017.
3
IT IS SO STIPULATED.
4
DATED: September 27, 2017
SANDERS PHILLIPS GROSSMAN, LLC
5
6
By: /s/ Timothy M. Clark
Timothy M. Clark
Lauren Welling
Attorneys for Plaintiffs
7
8
9
10
DATED: September 27, 2017
KING & SPALDING LLP
11
12
By: /s/ William E. Steimle
Donald F. Zimmer, Jr.
William E. Steimle
Attorneys for Defendants
13
14
15
16
Signature Attestation (N.D. Cal. L.R. 5-1(i)(3))
17
I, William E. Steimle, attest that concurrence in the filing of this document has been
18
obtained from each signatory whose ECF user ID and password are not being used in the
19
electronic filing of this document.
20
///
21
///
22
///
23
///
24
///
25
///
26
///
27
///
28
3
STIPULATION AND [PROPOSED] ORDER TO CONTINUE HEARING OF PLAINTIFF’S MOTION
TO DISMISS AND TO CONTINUE CASE MANAGEMENT CONFERENCE PURSUANT TO N.D.
CAL. CIV. L.R. 6-1
1
Having considered Plaintiffs’ and Defendants (collectively, the Parties’) Stipulation for
2
Order to Continue the October 12, 2017 hearing of the Plaintiff’s motion to dismiss McKesson
3
Corporation and Continue the October 12, 2017 case management conference, and good cause
4
appearing, the Parties’ Stipulation is GRANTED.
5
The October 12, 2017 hearing of the Plaintiff’s motion to dismiss McKesson Corporation
continued November 1
is advanced to November 2, 2017.
November 1
The October 12, 2017 case management conference is continued to November 2, 2017.
6
7
8
IT IS SO ORDERED.
9
10
11
12
September 28,
DATED: _____________2017
HONORABLE JON S. TIGAR
United States District Judge
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4
STIPULATION AND [PROPOSED] ORDER TO CONTINUE HEARING OF PLAINTIFF’S MOTION
TO DISMISS AND TO CONTINUE CASE MANAGEMENT CONFERENCE PURSUANT TO N.D.
CAL. CIV. L.R. 6-1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?